Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections
Primary Purpose
Malaria Diagnosis, Malaria,Falciparum
Status
Unknown status
Phase
Not Applicable
Locations
Myanmar
Study Type
Interventional
Intervention
hsRDT
Sponsored by
About this trial
This is an interventional diagnostic trial for Malaria Diagnosis focused on measuring hsRDT, usRDT, Reactive Case Detection (RCD), High risk for malaria
Eligibility Criteria
Inclusion Criteria:
- Age at least 5 years old
- Resident of the villages, or temporary visitors, or co-workers or co-travelers of index case
- Willingness to participate in the study evident by informed consent
Exclusion Criteria:
- Presence of severe clinical illness including severe malaria
- Non-resident index cases
- Refusal to participate in the study
Sites / Locations
- University Research Co., LLC (URC)Recruiting
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Diagnostic performance of hsRDT
Arm Description
Comparing diagnostic power of two diagnostics
Outcomes
Primary Outcome Measures
Prevalence of malaria infections identified by the new hsRDT
Outcomes measured by malaria test positivity rate by cRDT, hsRDT and PCR, respectively
Secondary Outcome Measures
Diagnostic performance characteristics of hsRDT versus cRDT using PCR as gold standard, in the detection of P.falciparum infections
Outcomes measured between hsRDT and cRDT
Correlation of detection capability between cRDT and hsRDT
Outcomes measured by correlation of test positivity rates
Risk factors associated with malaria infection cases
Outcomes will be measured by relative risk of malaria in association with different risk factors identified
Full Information
NCT ID
NCT03511443
First Posted
March 19, 2018
Last Updated
April 17, 2018
Sponsor
University Research Co, LLC
Collaborators
Duke University, United States Agency for International Development (USAID), Department of Medical Research, Lower Myanmar, Centers for Disease Control and Prevention
1. Study Identification
Unique Protocol Identification Number
NCT03511443
Brief Title
Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections
Official Title
Evaluation of the Performance of a Highly-sensitive Rapid Diagnostic Test (RDT) Versus Conventional RDT, Compared With PCR as the Gold Standard, in Reactive Case Detection of Malaria Infections in Rakhine State, Myanmar
Study Type
Interventional
2. Study Status
Record Verification Date
April 2018
Overall Recruitment Status
Unknown status
Study Start Date
October 2, 2017 (Actual)
Primary Completion Date
June 28, 2018 (Anticipated)
Study Completion Date
October 1, 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Research Co, LLC
Collaborators
Duke University, United States Agency for International Development (USAID), Department of Medical Research, Lower Myanmar, Centers for Disease Control and Prevention
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
A systematic review assessing the role, appropriateness and benefits of the active case detection strategy, both proactive and reactive, in low malaria transmission settings. A common indication is that more studies should be carried out to optimize the ACD strategy to the local context, or to provide evidence for the adoption of improved methods. One possible improved method is the use of more accurate diagnostic tools, such as the hsRDT proposed in this study, with an increased capacity to detect lower levels of parasitemia. It can provide a timely and relevant contribution for their development of national Standard Operating Procedures for a screening tool in the reactive case detection strategy.
Detailed Description
The study is conducted in the areas under Sakhanmaw Rural Health Center, Ann Township in Southern Rakhine State, Myanmar.
General objective was to evaluate the performance of the new highly-sensitive rapid diagnostic test (RDT) developed by SD Bioline versus conventional RDT, compared with PCR as the gold standard, in reactive case detection of malaria infections in Rakhine State, Myanmar.
Specific objectives
To evaluate the prevalence of malaria identified by the new hsRDT in comparison with that by cRDT and PCR
To assess the diagnostic performance characteristics of hsRDT versus cRDT, using PCR as gold standard, in the detection of P.falciparum infections
To evaluate correlation of detection capability between cRDT and hsRDT
To identify risk factors associated with malaria infection, including but not limited to, socio-demographic factors and travel history related with malaria index cases
This is a prospective community-based single-center reactive case detection (RCD) study to assess the performance of hsRDT versus cRDT in identifying individuals with malaria infection ("Secondary case") in a population living and/or working in a close physical proximity to an "index case." All cases parasitologically confirmed by conventional RDT will be promptly notified to the study team and interviewed with a standardized case investigation form at their home, possibly within 3 days. All members of the primary case household and those of the nearest 10 households, aged 5 years and above, will be invited to participate in the study. A blood spot will be collected for subsequent PCR analysis. At least 50 index cases are targeted for investigation and reactive case detection and an estimated number of 1,980 persons will be involved in the study.
It is expected that this study will be an important input for the national malaria control program in Myanmar as they develop the strategies to conduct reactive case detection.
A suitable statistical software, e.g. STATA will be used to analyze the data resulting from the participant interviews and 3 parasitological tests. Logistic regression models will be developed to examine factors significantly associated with malaria infections.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malaria Diagnosis, Malaria,Falciparum
Keywords
hsRDT, usRDT, Reactive Case Detection (RCD), High risk for malaria
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
If P.f malaria case were detected, the responsible malaria worker or basic health staff will inform to survey team and blood samples for cRDT, hsRDT, Dried Blood Spot for PCR will be collected from index case and contacts (nearby 10-household members and peers). Then the results of cRDT and hsRDT will be confirmed by PCR for evaluating their performance. Then the applicability of hsRDT to detect low parasitaemia for enhancing malaria elimination activities will be evaluated.
Masking
None (Open Label)
Allocation
N/A
Enrollment
1980 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Diagnostic performance of hsRDT
Arm Type
Other
Arm Description
Comparing diagnostic power of two diagnostics
Intervention Type
Diagnostic Test
Intervention Name(s)
hsRDT
Other Intervention Name(s)
Highly sensitive RDT is also used as ultrasensitive RDT
Intervention Description
Testing highly sensitive RDT detection for low parasitemia
Primary Outcome Measure Information:
Title
Prevalence of malaria infections identified by the new hsRDT
Description
Outcomes measured by malaria test positivity rate by cRDT, hsRDT and PCR, respectively
Time Frame
PCR diagnosis of samples will occur after 10 months of data collection.
Secondary Outcome Measure Information:
Title
Diagnostic performance characteristics of hsRDT versus cRDT using PCR as gold standard, in the detection of P.falciparum infections
Description
Outcomes measured between hsRDT and cRDT
Time Frame
Outcomes will be analyzed after 10 months of data collection
Title
Correlation of detection capability between cRDT and hsRDT
Description
Outcomes measured by correlation of test positivity rates
Time Frame
PCR results will be analyzed during month 10
Title
Risk factors associated with malaria infection cases
Description
Outcomes will be measured by relative risk of malaria in association with different risk factors identified
Time Frame
Outcome will be measured/analyzed in month 10, after PCR results are released
10. Eligibility
Sex
All
Minimum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age at least 5 years old
Resident of the villages, or temporary visitors, or co-workers or co-travelers of index case
Willingness to participate in the study evident by informed consent
Exclusion Criteria:
Presence of severe clinical illness including severe malaria
Non-resident index cases
Refusal to participate in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
San Kyawt Khine, MD
Phone
959450542076
Email
skkhine.khine75@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Kyaw Myint Tun, MD
Phone
9595039861
Email
ktun@urc-chs.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Saw Lwin, MD
Organizational Affiliation
University Research Co, LLC
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Feliciano Monti, MD
Organizational Affiliation
US Embassy, Yangon
Official's Role
Study Chair
Facility Information:
Facility Name
University Research Co., LLC (URC)
City
Yangon
Country
Myanmar
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kyaw Myint Tun
Phone
9595039861
Email
ktun@urc-chs.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
26783752
Citation
Chen I, Clarke SE, Gosling R, Hamainza B, Killeen G, Magill A, O'Meara W, Price RN, Riley EM. "Asymptomatic" Malaria: A Chronic and Debilitating Infection That Should Be Treated. PLoS Med. 2016 Jan 19;13(1):e1001942. doi: 10.1371/journal.pmed.1001942. eCollection 2016 Jan.
Results Reference
background
PubMed Identifier
21311588
Citation
malERA Consultative Group on Health Systems and Operational Research. A research agenda for malaria eradication: health systems and operational research. PLoS Med. 2011 Jan 25;8(1):e1000397. doi: 10.1371/journal.pmed.1000397.
Results Reference
background
PubMed Identifier
26701778
Citation
Adams M, Joshi SN, Mbambo G, Mu AZ, Roemmich SM, Shrestha B, Strauss KA, Johnson NE, Oo KZ, Hlaing TM, Han ZY, Han KT, Thura S, Richards AK, Huang F, Nyunt MM, Plowe CV. An ultrasensitive reverse transcription polymerase chain reaction assay to detect asymptomatic low-density Plasmodium falciparum and Plasmodium vivax infections in small volume blood samples. Malar J. 2015 Dec 23;14:520. doi: 10.1186/s12936-015-1038-z.
Results Reference
background
PubMed Identifier
25964304
Citation
Cheng Z, Wang D, Tian X, Sun Y, Sun X, Xiao N, Zheng Z. Capture and Ligation Probe-PCR (CLIP-PCR) for Molecular Screening, with Application to Active Malaria Surveillance for Elimination. Clin Chem. 2015 Jun;61(6):821-8. doi: 10.1373/clinchem.2014.237115. Epub 2015 May 11.
Results Reference
background
PubMed Identifier
19848588
Citation
Okell LC, Ghani AC, Lyons E, Drakeley CJ. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis. 2009 Nov 15;200(10):1509-17. doi: 10.1086/644781.
Results Reference
background
PubMed Identifier
24989601
Citation
Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, Nosten F, Snounou G, White NJ. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014 Sep;52(9):3303-9. doi: 10.1128/JCM.01057-14. Epub 2014 Jul 2.
Results Reference
background
PubMed Identifier
26424000
Citation
Imwong M, Nguyen TN, Tripura R, Peto TJ, Lee SJ, Lwin KM, Suangkanarat P, Jeeyapant A, Vihokhern B, Wongsaen K, Van Hue D, Dong le T, Nguyen TU, Lubell Y, von Seidlein L, Dhorda M, Promnarate C, Snounou G, Malleret B, Renia L, Keereecharoen L, Singhasivanon P, Sirithiranont P, Chalk J, Nguon C, Hien TT, Day N, White NJ, Dondorp A, Nosten F. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J. 2015 Sep 30;14:381. doi: 10.1186/s12936-015-0906-x.
Results Reference
background
PubMed Identifier
23940677
Citation
Searle KM, Shields T, Hamapumbu H, Kobayashi T, Mharakurwa S, Thuma PE, Smith DL, Glass G, Moss WJ. Efficiency of household reactive case detection for malaria in rural Southern Zambia: simulations based on cross-sectional surveys from two epidemiological settings. PLoS One. 2013 Aug 6;8(8):e70972. doi: 10.1371/journal.pone.0070972. Print 2013.
Results Reference
background
PubMed Identifier
26852118
Citation
van Eijk AM, Ramanathapuram L, Sutton PL, Kanagaraj D, Sri Lakshmi Priya G, Ravishankaran S, Asokan A, Tandel N, Patel A, Desai N, Singh R, Sullivan SA, Carlton JM, Srivastava HC, Eapen A. What is the value of reactive case detection in malaria control? A case-study in India and a systematic review. Malar J. 2016 Feb 6;15:67. doi: 10.1186/s12936-016-1120-1.
Results Reference
background
PubMed Identifier
26931488
Citation
Hustedt J, Canavati SE, Rang C, Ashton RA, Khim N, Berne L, Kim S, Sovannaroth S, Ly P, Menard D, Cox J, Meek S, Roca-Feltrer A. Reactive case-detection of malaria in Pailin Province, Western Cambodia: lessons from a year-long evaluation in a pre-elimination setting. Malar J. 2016 Mar 1;15:132. doi: 10.1186/s12936-016-1191-z.
Results Reference
background
Learn more about this trial
Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections
We'll reach out to this number within 24 hrs